Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dunn School Student in Science Communication Competition Regional Final

General

Using a paper crane as a prop, Fodor lab DPhil student Bernadeta Dadonaite explained the potential of DNA origami technology to a capacity audience at the FameLab 2017 regional final at the Bullingdon bar and club in Oxford on 8 March.

FameLab helps communicate science to the general public in digestible three-minute competitive performances by students and researchers across the fields of science and engineering.  Running in over 25 countries worldwide the competition started at Cheltenham Science Festival in 20015.  Science Oxford runs the Oxford heats. 

Bernadeta was one of eight regional finalists grilled by a judging panel of experts from across Oxford: John Runions,  Reader in Cell and Molecular Biology at Oxford Brookes University; Jennifer Rogers, Vice President for External Affairs at the Royal Statistical Society and Director of Statistical Consultancy Services at Oxford University; and Alison Woollard, Oxford University Academic Champion for Public Engagement with Research. YouTube science vlogger Sally le Page hosted the event.

Read more (Sir William Dunn School of Pathology website)

Similar stories

Prestigious award for Oxford professor's diabetes work

A University of Oxford professor has been awarded the 2021 EASD-Novo Nordisk Foundation Prize for Excellence for his decades of effort to understand, prevent and combat type 1 diabetes.

COVID winter plan: UK blueprint doesn’t go far enough – here’s a health expert’s alternative

Wellcome accolades for Dr Douglas

Dr Alexander (Sandy) Douglas, an investigator at the Jenner Institute, Nuffield Department of Medicine, has recently received two prestigious Wellcome accolades.

FOCUS4: a flagship trial in colorectal cancer

Professor Tim Maughan (Department of Oncology) outlines the flagship work of the FOCUS4 trials, whose results were presented last weekend at the European Society of Medical Oncology (ESMO) annual meeting

Oxford and Oracle partner to speed identification of COVID-19 variants

The fast spread of the highly infectious Delta variant underscores the need for faster identification of COVID-19 mutations. Uniting governments and medical communities in this challenge, the University of Oxford and Oracle’s Global Pathogen Analysis System (GPAS) is now being used by organizations on nearly every continent. Institutions using the platform include: the University of Montreal Hospital Centre Research Centre, the Institute of Public Health Research of Chile, the Oxford University Clinical Research Unit in Vietnam, the Institute of Clinical Pathology and Medical Research – New South Wales Pathology, and Oxford Nanopore Technologies. GPAS is also now part of the Public Health England New Variant Assessment Platform.

Vaccinated groups at highest risk of Covid-19 hospitalisation and death identified using new QCovid tool

Researchers from the University of Oxford have today reported on findings on the vaccinated people who are at greatest risk from severe Covid-19 leading to hospitalisation or death from 14 days post the second dose vaccination, when substantial immunity should be expected.